Balaxi Pharmaceuticals Ltd.

•

balaxipharma.inBSE: -NSE: BALAXI

Market Cap₹ 131 Cr.

Current Price

High / Low₹ 48 / 15

Stock P/E53.9

Book Value₹ 45

Price to Book0.35

Dividend Yield0.00 %

ROCE3.5 %

ROE0.6 %

Face Value₹ 2

Add ratio to table

ABOUT

AI Sector View

AI GENERATED

Oil Gas & Consumable Fuels

Reduce

Sector economics are clouded by input volatility and uneven volume trends. WPI fuel inflation is very high at 20.05% (Jul/26), crude oil output is -5.3% YoY (2026-07), natural gas is -3.7% YoY (2026-07), and natural gas consumption is -3.0% YoY (2026-06), although refinery products grew 2.7% YoY (2026-07) and coal was 7.6% YoY (2026-07). Heavy FPI outflows of INR -15293 crore over 3 months to 2026-08-31 and negative oil-linked news flow reinforce the underweight.

Confidence

78%

View full sector analysis →

PROS

Company maintains a comfortable, low leverage position

CONS

Operating cash flow has been negative in recent years
Recent results are weak - TTM profit is down 86.4% versus prior year
A large part of profit comes from other income (53.3% of PBT)
Receivables are growing faster than sales - a possible quality concern
Company has a low return on equity of 3.7% over last 3 years
Company has a low return on capital employed of 6.3%

* The pros and cons are machine generated based on quantitative rules.

Peer comparison

Oil Gas & Consumable FuelsTradingTrading

Part ofNIFTY 50 NIFTY 500 NIFTY LARGEMIDCAP 250 NIFTY 100 NIFTY 200

S.No.	Name
1.	ADANIENT	3100.00	56.37	419654.01	0.04	-1461.54	-249.67	32923.98	49.92	13.30	15.57
2.	AEGISLOG	1341.45	37.63	47084.89	0.65	544.84	210.70	2356.86	37.07	19.76	30.28
3.	PREMIERENE	978.00	26.66	44396.46	0.10	471.92	53.32	2462.59	35.25	33.72	29.03
4.	CPPLUS	3743.15	92.78	44281.63	0.04	142.20	332.51	1402.42	89.51	29.48	14.52
5.	REDINGTON	377.85	17.37	29539.35	1.59	453.49	94.65	34922.47	34.57	18.96	2.03
6.	HONASA	470.90	61.69	15352.48	0.64	90.45	118.87	755.95	27.00	20.87	14.58
7.	LLOYDSENT	70.44	95.76	10753.03	0.21	109.98	-55.77	563.03	70.15	12.84	18.07
8.	SGMART	772.60	78.32	9737.48	0.00	455.80	1310.71	13085.70	1044.08	10.43	4.49
9.	MMTC	62.72	21.03	9408.00	0.00	104.24	135.52	0.68	-50.00	33.46	-1423.53
10.	ENTERO	1821.70	63.22	7928.60	0.00	52.05	72.17	1940.50	38.23	10.93	5.00
11.	EBGNG	675.50	54.07	7701.48	0.00	28.93	56.21	412.46	32.08	20.58	11.97
12.	BALAXI	23.68	53.93	130.73	0.00	1.30	347.24	80.68	14.05	3.48	5.78

Detailed Comparison with:

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
	66	55	61	60	66	77	73	76	71	56	73	71	81
	57	44	47	46	56	67	69	64	67	55	69	71	78
Operating Profit	9	11	14	13	10	11	4	13	4	1	3	0	3
OPM %	13.40%	19.66%	22.47%	22.50%	15.36%	13.67%	5.44%	16.47%	5.87%	2.08%	4.26%	0.17%	3.82%
	-48	6	2	-1	-2	-4	4	-2	-2	2	0	3	-1
Interest	0	0	0	1	0	0	1	1	1	1	1	1	1
Depreciation	0	1	0	1	0	0	0	0	0	0	1	1	1
Profit before Tax	-39	16	14	11	7	6	6	10	1	1	2	1	2
Tax %	-4.90%	7.85%	4.77%	4.87%	12.20%	17.45%	11.70%	10.66%	67.78%	84.78%	81.37%	56.43%	37.89%
Net Profit	0	0	0	0	6	5	5	9	0	0	0	1	1
	-8.10	2.82	2.66	2.08	1.17	0.84	0.97	1.56	0.05	0.04	0.06	0.11	0.24

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026	TTM
	14	46	231	279	336	241	293	270	280
	12	37	189	229	279	197	260	261	273
Operating Profit	2	8	43	51	57	45	32	10	7
OPM %	11.46%	18.09%	18.45%	18.19%	17.07%	18.46%	11.01%	3.55%	2.66%
	1	1	2	5	3	-38	2	3	4
Interest	0	0	0	1	1	3	4	5	4
Depreciation	0	0	0	1	2	2	2	2	3
Profit before Tax	2	9	44	55	57	2	29	5	6
Tax %	19.41%	30.59%	13.97%	12.59%	19.25%	218.44%	12.55%	73.23%	62.69%
Net Profit	2	6	38	48	46	-2	25	1	2
EPS	6.47	8.12	38.14	47.66	45.40	-6.70	5.01	3.14	—
Dividend Payout %	0.00%	0.00%	0.00%	1.04%	0.00%	0.00%	0.00%	0.00%	—

COMPOUNDED SALES GROWTH

10 Years:: —
5 Years:: 3%
3 Years:: -7%

COMPOUNDED PROFIT GROWTH

10 Years:: —
5 Years:: -14%
3 Years:: -31%

STOCK PRICE CAGR

10 Years:: 22%
5 Years:: -27%
3 Years:: -37%
1 Year:: -49%

RETURN ON EQUITY

10 Years:: —
5 Years:: 19%
3 Years:: 4%
Last Year:: 1%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity Capital	3	10	10	10	10	11	11	11
	0	18	55	103	162	187	221	238
	0	0	4	4	13	19	53	58
Trade Payables	2	5	25	49	35	29	16	21
	1	3	6	11	19	12	9	9
Total Liabilities	6	36	100	176	240	258	310	337
	0	0	2	29	41	41	41	82
Capital Work in Progress	0	0	0	1	3	2	22	0
	0	0	3	0	0	0	0	0
	0	1	14	99	105	82	78	83
	0	0	0	0	0	56	111	136
Cash & Bank	0	4	2	7	28	62	39	15
	6	31	79	41	62	15	19	21
Total Assets	6	36	100	176	240	258	310	337

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
	-1	-13	3	40	18	5	-35	-4
Cash from Investing	-0	-0	-6	-28	-11	-1	-22	-21
Cash from Financing	0	18	4	-0	26	30	34	0
	-2	4	-2	6	21	34	-23	-25

Ratios

Consolidated Figures in Rs. Crores / View Standalone

	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026

Shareholding Pattern

Numbers in percentages

	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
	65.99	65.99	65.99	65.99	65.99	65.99	65.99	65.99	65.99
	16.88	16.48	16.48	16.02	8.86	3.50	1.74	0.00	0.00
	0.02	0.02	0.02	0.02	0.02	0.02	0.02	2.56	2.56
Government	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
	17.11	17.49	17.51	17.96	25.12	30.49	32.25	31.45	31.45

Documents

Corporate disclosures, annual reports, credit ratings, and concall transcripts

2026-09-07

Updates

2026-09-07 - BALAXI PHARMACEUTICALS LIMITED has informed the Exchange regarding '''RTA Report for Re-lodgement of Transfer Requests of Physical Shares for the period ended August 2026 .'.

2026-08-31

General Updates

2026-08-31 - Balaxi Pharmaceuticals Limited has informed the Exchange about the receipt of WHO-GMP Certification for Company's Pharmaceutical Formulation Manufacturing Facility.

2026-08-24

Change in Director(s)

2026-08-24 - BALAXI PHARMACEUTICALS LIMITED has informed the Exchange regarding Change in Director(s) of the company.

2026-08-24

Shareholders meeting

2026-08-24 - BALAXI PHARMACEUTICALS LIMITED has submitted the Exchange a copy Srutinizers Report of Annual General Meeting held on 24th August, 2026. Further, the company has informed the Exchange regarding Voting Results.

2026-08-24

Shareholders meeting

2026-08-24 - BALAXI PHARMACEUTICALS LIMITED has informed the Exchange regarding Proceedings of the 83rd Annual General Meeting held on 24th August, 2026

2026-08-14

Copy of Newspaper Publication

2026-08-14 - BALAXI PHARMACEUTICALS LIMITED has informed the Exchange about Copy of Newspaper Publication.

2026-08-11

Copy of Newspaper Publication

2026-08-11 - BALAXI PHARMACEUTICALS LIMITED has informed the Exchange about Copy of Newspaper Publication.

2026-08-10

Corrigendum

2026-08-10 - BALAXI PHARMACEUTICALS LIMITED has informed the Exchange regarding Corrigendum to Notice of the 83rd Annual General Meeting.

2026-08-07

Updates

2026-08-07 - BALAXI PHARMACEUTICALS LIMITED has informed the Exchange regarding '''RTA Report for Re-lodgement of Transfer Requests of Physical Shares for the period ended July 2026".

News

Recent coverage and analyst commentary for BALAXI

Loading news…

🤖

AI Stock Analyst

Balaxi Pharmaceuticals Ltd.

🔒

Sign in to Chat with AI

✨ Sign In to Chat

Free 5nance Account

Name

ADANIENT

3100.00

56.37

419654.01

0.04

-1461.54

-249.67

32923.98

49.92

13.30

15.57

AEGISLOG

1341.45

37.63

47084.89

0.65

544.84

210.70

2356.86

37.07

19.76

30.28

PREMIERENE

978.00

26.66

44396.46

0.10

471.92

53.32

2462.59

35.25

33.72

29.03

CPPLUS

3743.15

92.78

44281.63

0.04

142.20

332.51

1402.42

89.51

29.48

14.52

REDINGTON

377.85

17.37

29539.35

1.59

453.49

94.65

34922.47

34.57

18.96

2.03

HONASA

470.90

61.69

15352.48

0.64

90.45

118.87

755.95

27.00

20.87

14.58

LLOYDSENT

70.44

95.76

10753.03

0.21

109.98

-55.77

563.03

70.15

12.84

18.07

SGMART

772.60

78.32

9737.48

0.00

455.80

1310.71

13085.70

1044.08

10.43

4.49

MMTC

62.72

21.03

9408.00

0.00

104.24

135.52

0.68

-50.00

33.46

-1423.53

ENTERO

1821.70

63.22

7928.60

0.00

52.05

72.17

1940.50

38.23

10.93

5.00

EBGNG

675.50

54.07

7701.48

0.00

28.93

56.21

412.46

32.08

20.58

11.97

BALAXI

23.68

53.93

130.73

0.00

1.30

347.24

80.68

14.05

3.48

5.78

Jun 2023

Sep 2023

Dec 2023

Mar 2024

Jun 2024

Sep 2024

Dec 2024

Mar 2025

Jun 2025

Sep 2025

Dec 2025

Mar 2026

Jun 2026

Operating Profit

OPM %

13.40%

19.66%

22.47%

22.50%

15.36%

13.67%

5.44%

16.47%

5.87%

2.08%

4.26%

0.17%

3.82%

-48

-1

-2

-4

-2

-1

Interest

Depreciation

Profit before Tax

-39

Tax %

-4.90%

7.85%

4.77%

4.87%

12.20%

17.45%

11.70%

10.66%

67.78%

84.78%

81.37%

56.43%

37.89%

Net Profit

-8.10

2.82

2.66

2.08

1.17

0.84

0.97

1.56

0.05

0.04

0.06

0.11

0.24

Mar 2019

Mar 2020

Mar 2021

Mar 2022

Mar 2023

Mar 2024

Mar 2025

Mar 2026

TTM

231

279

336

241

293

270

280

189

229

279

197

260

261

273

Operating Profit

OPM %

11.46%

18.09%

18.45%

18.19%

17.07%

18.46%

11.01%

3.55%

2.66%

-38

Interest

Depreciation

Profit before Tax

Tax %

19.41%

30.59%

13.97%

12.59%

19.25%

218.44%

12.55%

73.23%

62.69%

Net Profit

-2

EPS

6.47

8.12

38.14

47.66

45.40

-6.70

5.01

3.14

—

Dividend Payout %

0.00%

1.04%

0.00%

—

Mar 2019

Mar 2020

Mar 2021

Mar 2022

Mar 2023

Mar 2024

Mar 2025

Mar 2026

Equity Capital

103

162

187

221

238

Trade Payables

Total Liabilities

100

176

240

258

310

337

Capital Work in Progress

105

111

136

Cash & Bank

Total Assets

100

176

240

258

310

337

Mar 2019

Mar 2020

Mar 2021

Mar 2022

Mar 2023

Mar 2024

Mar 2025

Mar 2026

-1

-13

-35

-4

Cash from Investing

-0

-6

-28

-11

-1

-22

-21

Cash from Financing

-0

-2

-23

-25

Mar 2019

Mar 2020

Mar 2021

Mar 2022

Mar 2023

Mar 2024

Mar 2025

Mar 2026

Jun 2024

Sep 2024

Dec 2024

Mar 2025

Jun 2025

Sep 2025

Dec 2025

Mar 2026

Jun 2026

65.99

16.88

16.48

16.02

8.86

3.50

1.74

0.00

0.02

2.56

Government

0.00

17.11

17.49

17.51

17.96

25.12

30.49

32.25

31.45

Balaxi Pharmaceuticals Ltd.

AI Sector View

Peer comparison

Quarterly Results

Profit & Loss

Balance Sheet

Corporate actions

Cash Flows

Ratios

Shareholding Pattern

Documents

News

Sign in to Chat with AI

Balaxi Pharmaceuticals Ltd.

AI Sector View

Peer comparison

Quarterly Results

Profit & Loss

Balance Sheet

Corporate actions

Cash Flows

Ratios

Shareholding Pattern

Documents

News

Sign in to Chat with AI